The Potential Role of the Extracellular Matrix Glycoprotein Reelin in Glioblastoma Biology

Pharmaceuticals (Basel). 2024 Mar 21;17(3):401. doi: 10.3390/ph17030401.

Abstract

Glioblastoma, the most common and lethal primary adult brain tumor, cannot be successfully removed surgically due to its highly invasive nature. Therapeutically, approaches must be aimed at a systemic brain disease and not merely at a tumor located within the brain, unless a successful containment strategy can be found. Reelin, an extracellular matrix glycoprotein, plays an important role in neuronal migration and serves here as a natural stop signal. Interestingly, the expression of reelin is negatively associated with tumor grade and, within glioblastoma, correlates with increased overall survival. To further elucidate a potential biological reason for these findings, we looked at the cellular behavior of glioblastoma cell lines grown on a pure fibronectin matrix or a matrix with reelin inserts. While reelin had no significant effects on cellular metabolism, proliferation, or resistance to chemotherapeutic agents, it did significantly affect the cells' interaction with fibronectin. Both matrix attachment and detachment were modulated by reelin, and thus, the invasion and motility of cells interacting with a reelin-containing matrix were altered. The data presented in this work strongly suggest that reelin might be a potential modulator of underlying molecular mechanisms that contribute to glioblastoma invasion.

Keywords: extracellular matrix; fibronectin; glioblastoma; invasion; motility; reelin.

Grants and funding

M.-A.W. and K.-M.D. received funding from the Förderkreis für tumor-und leukämiekranke Kinder Ulm e.V., while E.O. was funded by The Experimental Medicine Program of the International Graduate School in Molecular Medicine of Ulm University.